Hydrogen breathing, a novel and gentle adjuvant therapy, is gaining increasing attention in the field of lung cancer care, offering a ray of hope for patients seeking additional support alongside standard treatments. At its core, hydrogen acts as a powerful selective antioxidant. It specifically neutralizes harmful reactive oxygen species (ROS) that damage healthy cells and fuel cancer progression, without disrupting beneficial oxidative processes in the body. For lung cancer patients, this antioxidant effect is particularly valuable: it helps alleviate oxidative stress caused by the tumor itself and harsh treatments like chemotherapy and radiation, reducing treatment-related side effects such as fatigue, nausea, and tissue inflammation. Moreover, hydrogen breathing may play a role in modulating the tumor microenvironment. Research suggests it can inhibit excessive inflammatory responses, creating a less favorable environment for cancer cell growth and metastasis. It also shows potential in enhancing the efficacy of conventional therapies—by improving cellular oxygenation and reducing treatment resistance, hydrogen may help make chemotherapy or radiation more effective, while protecting normal lung tissue from collateral damage. Crucially, hydrogen breathing is non-invasive, safe, and well-tolerated. Patients can inhale hydrogen gas through a portable device at home, with no reported severe adverse effects. This ease of use makes it a practical complementary option for those looking to improve their quality of life during treatment. While hydrogen breathing is not a standalone cure for lung cancer, its ability to reduce side effects, protect healthy cells, and potentially boost treatment outcomes positions it as a promising supportive tool. For lung cancer patients navigating the challenges of treatment, it offers a gentle, accessible way to support their body’s resilience and enhance overall well-being. 需要我把这篇文章**精简到300字**，并补充**适合社交媒体传播的英文标签**吗？